Evidence map›Paper›PMID 26982073›Full record

ArticlePloS one2016

The Angiotensin Converting Enzyme Insertion/Deletion Polymorphism Modifies Exercise-Induced Muscle Metabolism.

David Vaughan, Michael Brogioli, Thomas Maier, Andy White, Sarah Waldron, Jörn Rittweger, Marco Toigo, Jessica Wettstein, Endre Laczko, Martin Flück

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Epigenetic Modulation of the ACE System Underlies the Slow Aerobic Muscle Phenotype and Metabolic Exercise Response.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  4. International journal of molecular sciences · 2026
    Article
  5. Medicina (Kaunas, Lithuania) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

David VaughanInstitute for Biomedical Research into Human Movement and Health, Manchester Metropolitan University, Manchester, United Kingdom.
Michael BrogioliInstitute for Biomedical Research into Human Movement and Health, Manchester Metropolitan University, Manchester, United Kingdom.
Thomas MaierInstitute for Biomedical Research into Human Movement and Health, Manchester Metropolitan University, Manchester, United Kingdom.
Andy WhiteChester Marathon, Chester, United Kingdom.
Sarah WaldronInstitute for Biomedical Research into Human Movement and Health, Manchester Metropolitan University, Manchester, United Kingdom.
Jörn RittwegerInstitute for Biomedical Research into Human Movement and Health, Manchester Metropolitan University, Manchester, United Kingdom.
Marco ToigoUniversity Hospital Balgrist, University of Zurich, Zurich, Switzerland.
Jessica WettsteinUniversity Hospital Balgrist, University of Zurich, Zurich, Switzerland.
Endre LaczkoFunctional Genomics Center Zürich, UZH/ETHZ, Zurich, Switzerland.
Martin FlückInstitute for Biomedical Research into Human Movement and Health, Manchester Metropolitan University, Manchester, United Kingdom.
Manchester Metropolitan University · GBUniversitätsklinik Balgrist · CHUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveA silencer region (I-allele) within intron 16 of the gene for the regulator of vascular perfusion, angiotensin-converting enzyme (ACE), is implicated in phenotypic variation of aerobic fitness and the development of type II diabetes. We hypothesised that the reportedly lower aerobic performance in non-carriers compared to carriers of the ACE I-allele, i.e. ACE-DD vs. ACE-ID/ACE-II genotype, is associated with alterations in activity-induced glucose metabolism and capillarisation in exercise muscle.

methodsFifty-three, not-specifically trained Caucasian men carried out a one-legged bout of cycling exercise to exhaustion and/or participated in a marathon, the aim being to identify and validate genotype effects on exercise metabolism. Respiratory exchange ratio (RER), serum glucose and lipid concentration, glycogen, and metabolite content in vastus lateralis muscle based on ultra-performance lipid chromatography-mass spectrometry (UPLC-MS), were assessed before and after the cycling exercise in thirty-three participants. Serum metabolites were measured in forty subjects that completed the marathon. Genotype effects were assessed post-hoc.

resultsCycling exercise reduced muscle glycogen concentration and this tended to be affected by the ACE I-allele (p = 0.09). The ACE-DD genotype showed a lower maximal RER and a selective increase in serum glucose concentration after exercise compared to ACE-ID and ACE-II genotypes (+24% vs. +2% and -3%, respectively). Major metabolites of mitochondrial metabolism (i.e. phosphoenol pyruvate, nicotinamide adenine dinucleotide phosphate, L-Aspartic acid, glutathione) were selectively affected in vastus lateralis muscle by exercise in the ACE-DD genotype. Capillary-to-fibre ratio was 24%-lower in the ACE-DD genotype. Individuals with the ACE-DD genotype demonstrated an abnormal increase in serum glucose to 7.7 mM after the marathon.

conclusionThe observations imply a genetically modulated role for ACE in control of glucose import and oxidation in working skeletal muscle. ACE-DD genotypes thereby transit into a pre-diabetic state with exhaustive exercise, which relates to a lowered muscle capillarisation, and deregulation of mitochondria-associated metabolism.

Indexed as

ExerciseINDEL MutationPolymorphism, GeneticGenotypeHumansMaleMuscle, SkeletalPeptidyl-Dipeptidase APhysical ExertionPeptidyl-Dipeptidase A

Identifiers

PMID26982073
PMCPMC4794249
OpenAlexW2300839147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.